CYCLERION THERAPEUTICS
Live / Applied — Fourth extension granted (statement of use) (as of 05 Feb 2026)
What this means for you
Not registered yet, but its 22 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97806500
- Mark type
- Stylized text
- Filed
- 22 Feb 2023
- Published for opposition
- 09 Jan 2024
- Attorney of record
- Anessa O. Kramer
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of ocular and ophthalmological diseases, respiratory system diseases, gastrointestinal system diseases, endocrine system diseases, cardiovascular system diseases, diseases of metabolism, central nervous system diseases, peripheral nervous system diseases, musculoskeletal system diseases, urinary system diseases, kidney diseases, hematological diseases, reproductive system diseases, integumentary system disease, skin and scalp diseases, immune system diseases, mitochondrial diseases, sleep disorders, fibrotic diseases, neuropsychiatric diseases, mood disorders, mental diseases, neurodegenerative diseases, endothelial dysfunction, thrombosis, ischemia, pain, inflammation, burns, ulcers and wounds
Owner
- Cyclerion Therapeutics, Inc., Cambridge, MA, US
- Cyclerion Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 05 Feb 2026 — SOU EXTENSION 4 GRANTED
- 05 Feb 2026 — SOU EXTENSION 4 FILED
- 05 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 30 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jul 2025 — SOU EXTENSION 3 GRANTED
- 30 Jul 2025 — SOU EXTENSION 3 FILED
- 30 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 14 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Feb 2025 — SOU EXTENSION 2 GRANTED
- 13 Feb 2025 — SOU EXTENSION 2 FILED
- 13 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Aug 2024 — SOU EXTENSION 1 GRANTED
- 29 Aug 2024 — SOU EXTENSION 1 FILED
- 29 Aug 2024 — SOU TEAS EXTENSION RECEIVED